With an eye to the future and meeting the needs of an increasingly demanding clientele to provide high-quality solutions, 303 Pharma launches the amino acid RH-ALFA 1 chain recombinant protein onto the market.
This is an expression of the Brescia company’s passion, for high-quality organic products. The amino acid RH-ALFA 1 chain is the result of careful research into innovation in the world of cosmeceuticals, carried out by the company’s two Partners and Founders, Marco Benedetti and Liliana Abrami. After a shared career path
within the pharmaceuticals and beauty products sector, Marco and Liliana have surpassed every technological frontier with the the amino acid RH-ALFA 1 chain

Traditional collagen used in cosmetics and aesthetics, can be bovine, swine or equine. This has limits deriving from the three-dimensional organisation of its elements which must be fragmented to obtain a reduction in molecular weight before performing their action.
The amino acid RH-ALFA 1 chain, with its monohelical molecular composition, is tissue-compatible at the epidermal level and easily absorbed.
It is produced from Japanese silkworms. In the Land of the Rising Sun, silkworms produce a filament from which an alpha collagen chain is extracted. This is compatible with human epidermal tissue. For this reason, the risk of triggering allergic reactions and sensitisation is zero.

With its registered office in Brescia and operational headquarters in Bergamo, the company has won a prominent place on the Italian and foreign market (Dubai, Kwait, India,
Germany, Austria and others) where health, wellness and beauty operators have welcomed the new amino acid RH-ALFA 1 chain. This was due to the professionalism and expertise of its founding partners, Liliana Abrami and Marco Benedetti, who built a team of scrupulous and attentive professionals. 303 Pharma will exhibit at the 22nd Sies-Valet International Congress of Aesthetic Medicine and Surgery, taking place from 22 to 24 February at the Palazzo dei
Congressi in Bologna. Expo 1 – Stand 29.